Jeffrey S. Hatfield, Chief Executive Officer at Vitae Pharmaceuticals, Inc (VTAE), sold 100,000 shares at $20.81 ($2.1M) on 2016-09-14, disclosed to the SEC on 2016-09-16.
Open-market sale of $2.1M VTAE by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.81 | 50,000 | $1.0M | 50.0% |
| 2 | $20.81 | 50,000 | $1.0M | 50.0% |
| Total | $20.81 avg | 100,000 | $2.1M | 100% |